Can Parents Sue If Their Kid Is Born With the 'Wrong' DNA?
By Kristen V. Brown,
Gizmodo
| 04. 18. 2017
It’s a nightmare scenario straight out of a primetime drama: a child-seeking couple visits a fertility clinic to try their luck with in-vitro fertilization, only to wind up accidentally impregnated by the wrong sperm.
In a fascinating legal case out of Singapore, the country’s Supreme Court ruled that this situation doesn’t just constitute medical malpractice. The fertility clinic, the court recently ruled, must pay the parents 30% of upkeep costs for the child for a loss of ‘genetic affinity.’ In other words, the clinic must pay the parents’ child support not only because they made a terrible medical mistake, but because the child didn’t wind up with the right genes.
At a time when rapidly advancing science and technology puts things like genetically engineering embryos to prevent disease in the realm of reality, the case sets an intriguing precedent. First, it places a monetary value on the amount of DNA that a child shares with their parents. And it suggests that the base genetic makeup of a child can actually be ‘wrong.’
“It’s suggesting that the child...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...